Summary & Overview
CPT 3051F: Hemoglobin A1c Result 7.0%–8.0%
CPT code 3051F denotes a hemoglobin A1c result between 7.0% and 8.0%, signaling suboptimal but near-target glycemic control for patients with diabetes. Nationally, HbA1c reporting codes like 3051F are used for clinical tracking, quality measurement, and performance programs focused on diabetes management and population health. The presence of this code supports monitoring of disease control and informs care coordination and program metrics.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the code, the typical service setting, and the role of the HbA1c result in care and quality programs. The publication summarizes how 3051F fits into laboratory reporting and quality measurement frameworks, highlights common modifiers and practical billing considerations where available, and notes when input fields are not provided.
This overview is intended for a national audience of billing managers, clinicians, and policy analysts who need a clear understanding of what CPT code 3051F represents, where it is used, and why it matters for diabetes quality measurement and related administrative workflows.
Billing Code Overview
CPT code 3051F indicates a hemoglobin A1c (HbA1c) result in the range of 7.0% to 8.0%. The HbA1c test reflects average blood glucose control over roughly three months and is used to monitor diabetes management.
Service type: Laboratory testing — diabetes glycemic control assessment
Typical site of service: Clinical laboratories, outpatient clinics, primary care offices, and endocrinology clinics
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with a history of type 2 diabetes mellitus presents to a primary care clinic for routine chronic disease management. The clinician orders a hemoglobin A1c (HbA1c) test to assess average glycemic control over the prior three months. A phlebotomy technician or medical assistant collects a venous blood sample during the visit; the specimen is sent to the clinic laboratory or an external reference lab. The most recent HbA1c result returns at 7.5%, which falls within the range represented by 3051F. The result is reviewed by the primary care clinician, documented in the electronic health record with the numeric value and interpretation, and used to guide ongoing medication management, counseling on lifestyle modification, and follow-up planning. Typical sites of service include outpatient primary care clinics, endocrinology offices, outpatient laboratory draw stations, and ambulatory care centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies to the claim |
95 | Synchronous telemedicine service rendered via real-time interactive audio and video |